Home › Following side effect concerns, Ariad suspends sales of cancer drug Iclusig at FDA's...
 

Keywords :   


Following side effect concerns, Ariad suspends sales of cancer drug Iclusig at FDA's...

2013-10-31 18:10:49| Biotech - Topix.net

Ariad Pharmaceuticals is suspending sales of its leukemia drug Iclusig because of concerns that patients could suffer from blood clots.

Tags: side sales effect drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.12Labelexpo South China 2024 features latest industry trends
03.12PPG Earns Two Awards During CARES 2024 Automotive Forums in U.S., Europe
03.12Filtrex 2025 to be Held in March
03.12Nu-Maber Italy adds dual ThermoFlexX Catena-E 80 units
03.12TEKLYNX assists with label compliance
03.12Megnajet supporting Arrow Systems\' growing digital portfolio
03.12WEG Achieves Gold Certification in EcoVadis for Second Consecutive Year
03.12Bank boss takes pay cut after employee 'tried to kill clients'
More »